JFA
JNBA Financial Advisors Portfolio holdings
AUM
$1.04B
This Quarter Return
+8.76%
1 Year Return
+13.36%
3 Year Return
+46.06%
5 Year Return
+82.07%
10 Year Return
+153.44%
AUM
$689M
AUM Growth
+$689M
(+13%)
Cap. Flow
+$31.2M
Cap. Flow
% of AUM
4.54%
Top 10 Holdings %
Top 10 Hldgs %
40.65%
Holding
683
New
55
Increased
177
Reduced
79
Closed
20
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 3.98% |
| 2 | Financials | 3.77% |
| 3 | Healthcare | 2.65% |
| 4 | Industrials | 2.62% |
| 5 | Consumer Discretionary | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Core 80/20 Aggressive Allocation ETF
AOA
$2.51B
| $706K | 0.1% |
10,542
-257
| -2% | -$17.2K |
|
102
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.08B
| $693K | 0.1% |
12,658
+6,433
| +103% | +$352K |
|
103
Wells Fargo
WFC
$258B
| $680K | 0.1% |
17,402
+214
| +1% | +$8.36K |
|
104
US Bancorp
USB
$75.5B
| $653K | 0.09% |
11,813
+191
| +2% | +$10.6K |
|
105
Blackrock
BLK
$170B
| $650K | 0.09% |
862
+41
| +5% | +$30.9K |
|
106
Exxon Mobil
XOM
$477B
| $624K | 0.09% |
11,180
-1,294
| -10% | -$72.2K |
|
107
Vanguard ESG US Stock ETF
ESGV
$11.1B
| $572K | 0.08% |
7,756
+1,814
| +31% | +$134K |
|
108
Chevron
CVX
$318B
| $569K | 0.08% |
5,428
+143
| +3% | +$15K |
|
109
Pfizer
PFE
$141B
| $560K | 0.08% |
15,461
+57
| +0.4% | +$2.07K |
|
110
SPDR S&P MidCap 400 ETF Trust
MDY
$23.6B
| $559K | 0.08% |
1,175
| – | – |
|
111
PepsiCo
PEP
$203B
| $545K | 0.08% |
3,855
+563
| +17% | +$79.6K |
|
112
Honeywell
HON
$136B
| $542K | 0.08% |
2,499
| – | – |
|
113
VanEck Gold Miners ETF
GDX
$19.6B
| $523K | 0.08% |
16,098
| – | – |
|
114
Allete
ALE
$3.68B
| $516K | 0.07% |
7,685
-3,604
| -32% | -$242K |
|
115
iShares Russell 1000 Growth ETF
IWF
$117B
| $511K | 0.07% |
2,101
-436
| -17% | -$106K |
|
116
CVS Health
CVS
$93B
| $510K | 0.07% |
6,775
+130
| +2% | +$9.79K |
|
117
CSX Corp
CSX
$60.2B
| $509K | 0.07% |
5,275
-100
| -2% | -$9.65K |
|
118
Travelers Companies
TRV
$62.3B
| $501K | 0.07% |
3,329
| – | – |
|
119
Merck
MRK
$210B
| $494K | 0.07% |
6,415
+1,341
| +26% | +$103K |
|
120
Nike
NKE
$110B
| $481K | 0.07% |
3,616
+860
| +31% | +$114K |
|
121
iShares Russell Mid-Cap ETF
IWR
$44B
| $467K | 0.07% |
6,315
| – | – |
|
122
Pearson
PSO
$9.09B
| $454K | 0.07% |
+42,445
| New | +$454K |
|
123
Gilead Sciences
GILD
$140B
| $454K | 0.07% |
7,018
-1
| -0% | -$65 |
|
124
iShares MSCI EAFE ETF
EFA
$65.4B
| $452K | 0.07% |
5,954
-356
| -6% | -$27K |
|
125
Novo Nordisk
NVO
$252B
| $450K | 0.07% |
6,672
| – | – |
|